Glycaemic control, markers of endothelial cell activation and oxidative stress in children with type 1 diabetes mellitus

被引:40
作者
Seckin, Dilara [1 ]
Ilhan, Necip
Ilhan, Nevin
Ertugrul, Sabahattin
机构
[1] Firat Univ, Tip Fak, Biyokimay AD, Firat Med Ctr,Dept Biochem, TR-23119 Elazig, Turkey
[2] Firat Univ, Firat Med Ctr, Dept Pediatry, TR-23119 Elazig, Turkey
关键词
type; 1; DM; oxidative stress; MDA; NO; VEGF; ICAM-1;
D O I
10.1016/j.diabres.2006.01.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The aim of this study was to compare the effect of glycaemic control on oxidative stress and biochemical markers of endothelial activation in type I diabetic children. Methods: Serum total cholesterol, HDL cholesterol, VLDL cholesterol, apolipoprotein At, apolipoprotein B, HbA(1c), MDA, VEGF, NO, ICAM levels were assessed in 100 children with type I DM aged 2-17 years. Study cases were evaluated in three groups in view of their mean HbA(1c) values, as metabolically well-controlled (HbA(1c) <= 8%) and poorly controlled (HbA(1c) > 8%) patients with DM and 40 healthy children were included as normal controls. Results: Levels of MDA, NO, VEGF, ICAM, apolipoprotein A l and apolipoprotein B in metabolically poorly controlled diabetic patients were significantly higher than control group (P < 0.05). In correlation analysis of HbA(1c) to VEGF, no significant correlations were detected in metabolically well-controlled DM, but there were significant correlations between HbA(1c) and NO, MDA, ICAM levels. In correlation analysis of HbA(1c) to VEGF, NO, MDA and ICAM levels, significant corTelations were detected in poorly controlled diabetics (P < 0.05). Conclusions: In the present study, increased levels of MDA, NO, ICAM-I and VEGF levels showed that especially metabolically poorly controlled DM children are at high risk of atherosclerosis and vascular complications of DM and that there is a significant relationship between HbA(1c) and oxidative stress. It may be appropriate to evaluate levels of VEGF and sICAM-1 as well as markers of oxidative stress in addition to routine laboratory assessments in evaluation of type I DM pediatric patients. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:191 / 197
页数:7
相关论文
共 58 条
  • [1] Deciphering diabetic nephropathy: progress using genetic strategies
    Adler, SG
    Pahl, M
    Seldin, MF
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2000, 9 (02) : 99 - 106
  • [2] VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS
    AIELLO, LP
    AVERY, RL
    ARRIGG, PG
    KEYT, BA
    JAMPEL, HD
    SHAH, ST
    PASQUALE, LR
    THIEME, H
    IWAMOTO, MA
    PARK, JE
    NGUYEN, HV
    AIELLO, LM
    FERRARA, N
    KING, GL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) : 1480 - 1487
  • [3] Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM -: Effect of intensive insulin treatment
    Albertini, JP
    Valensi, P
    Lormeau, B
    Aurousseau, MH
    Ferrière, F
    Attali, JR
    Gattegno, L
    [J]. DIABETES CARE, 1998, 21 (06) : 1008 - 1013
  • [4] *AM DIAB ASS, 2002, DIABETES CARE, V25, P33
  • [5] ANDERSEN AR, 1983, DIABETOLOGIA, V25, P496
  • [6] ROLE OF EDRF (NITRIC-OXIDE) IN DIABETIC RENAL HYPERFILTRATION
    BANK, N
    AYNEDJIAN, HS
    [J]. KIDNEY INTERNATIONAL, 1993, 43 (06) : 1306 - 1312
  • [7] BAUMGARTNERPARZER SM, 1995, DIABETOLOGIA, V38, P1367
  • [8] PREVALENCE AND DEVELOPMENT OF RETINOPATHY IN CHILDREN AND ADOLESCENTS WITH TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS - A LONGITUDINAL-STUDY
    BURGER, W
    HOVENER, G
    DUSTERHUS, R
    HARTMANN, R
    WEBER, B
    [J]. DIABETOLOGIA, 1986, 29 (01) : 17 - 22
  • [9] CERIELLO A, 1992, DIABETOLOGIA, V35, pA103
  • [10] Circulating plasma vascular endothelial growth factor and microvascular complications of Type 1 diabetes mellitus: the influence of ACE inhibition
    Chaturvedi, N
    Fuller, JH
    Pokras, F
    Rottiers, R
    Papazoglou, N
    Aiello, LP
    [J]. DIABETIC MEDICINE, 2001, 18 (04) : 288 - 294